NEXTERA AS has a total of 22 patent applications. It increased the IP activity by 600.0%. Its first patent ever was published in 2008. It filed its patents most often in China, Australia and Canada. Its main competitors in its focus markets biotechnology are KWEEK EN RESEARCHBED AGRICO BV, XINYI PHARMACEUTICAL FACTORY and SHANGHAI HIGH TECH UNITED BIO TECHNOLOGIES R & D CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Republic of Korea | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | United Kingdom | 1 | |
#8 | Japan | 1 | |
#9 | Russian Federation | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Nilssen Nicolay Rustad | 7 |
#2 | Sandlie Inger | 7 |
#3 | Frigstad Terje | 7 |
#4 | Loeset Geir Aage | 7 |
#5 | Berge-Seidl Sebastian | 6 |
#6 | Loset Geir Age | 4 |
#7 | Løset Geir Åge | 4 |
#8 | Leset Gejr Oge | 1 |
#9 | Geir Aage Loeset | 1 |
#10 | Aage Loeset Geir | 1 |
Publication | Filing date | Title |
---|---|---|
GB201718294D0 | Vector construct | |
EP2401373A1 | Signal sequence-independent pix phage display | |
KR20100063073A | pVII PHAGE DISPLAY |